Theralase Technologies Inc. (TLTFF)
OTCMKTS · Delayed Price · Currency is USD
0.1489
-0.0160 (-9.70%)
Aug 29, 2025, 2:56 PM EDT
Theralase Technologies Revenue
Theralase Technologies had revenue of 219.74K CAD in the quarter ending June 30, 2025, with 117.90% growth. This brings the company's revenue in the last twelve months to 1.07M, up 16.00% year-over-year. In the year 2024, Theralase Technologies had annual revenue of 1.03M, down -3.45%.
Revenue (ttm)
1.07M CAD
Revenue Growth
+16.00%
P/S Ratio
50.18
Revenue / Employee
53.40K CAD
Employees
20
Market Cap
39.29M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.03M | -36.88K | -3.45% |
Dec 31, 2023 | 1.07M | -68.26K | -6.00% |
Dec 31, 2022 | 1.14M | 357.93K | 45.85% |
Dec 31, 2021 | 780.64K | -148.48K | -15.98% |
Dec 31, 2020 | 929.12K | -34.93K | -3.62% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Longduoduo Company | 4.99M |
Theralase Technologies News
- 3 days ago - Theralase(R) Extends Warrants - Newsfile Corp
- 6 days ago - Theralase(R) Releases 2Q2025 Financial Statements - Newsfile Corp
- 5 weeks ago - Theralase(R) Closes Non-Brokered Private Placement - Newsfile Corp
- 2 months ago - Theralase(R) Extends Warrants - Newsfile Corp
- 2 months ago - Theralase(R) Closes Non-Brokered Private Placement - Newsfile Corp
- 2 months ago - Theralase Completes Annual General and Special Meeting - Newsfile Corp
- 3 months ago - Theralase Technologies Inc. (TLTFF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Theralase Annual General Meeting - Newsfile Corp